GlobalData on MSN
FDA clears MSD’s Keytruda combo plus Welireg for ccRCC treatment
The approvals are based on data from the pivotal Phase III LITESPARK-022 trial, which enrolled 1,841 patients.
Gilead and MSD will be filing the data from the Phase III trials of the once-weekly HIV pill to regulatory authorities.
Stakeholders are reluctant to publicly speculate on how much thresholds should be increased. Credit: Iryna Imago via Shutterstock. · Pharmaceutical Technology · Iryna Imago via Shutterstock. The above ...
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
MSD's plan to reduce its headcount by around 6,000, first revealed a couple of weeks ago, looks like it will start at its headquarters in Rahway, New Jersey. Confirmation of that has come in the form ...
Pharma company MSD is looking to fill up to 200 roles across its four Irish sites between now and the end of the year. The sector has been one of the few to find itself immune to the sharp rise in ...
LOUISVILLE, KY. (WDRB) -- A scathing state audit of the Metropolitan Sewer District means new policies and people are replacing some of the familiar fixtures. The audit by former Kentucky State ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results